Yasin Keshvargar
Lawyers

Filters
Energizer Holdings $600 million senior notes offering and cash tender offer
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Energizer Holdings, Inc. of $600 million aggregate principal amount…
SoftBank $20 billion monetization of its T-Mobile shareholdings
As part of the transaction, T-Mobile used proceeds from a new $16 billion stock offering to purchase its shares from SoftBank
Liberty Media rights offering
Davis Polk advised the dealer manager in connection with an SEC-registered rights offering by Liberty Media Corporation. A total of 29,594,089 new shares were subscribed for in the rights…
Generation Bio $230 million IPO
Davis Polk advised the representatives of the underwriters in connection with the $230 million initial public offering of 12,105,263 shares of common stock of Generation Bio Co., which…
Legend Biotech $487 million IPO
Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…
Humanigen $72 million stock PIPE offering
Davis Polk advised the placement agent in connection with a private placement pursuant to Rule 4(a)(2) by Humanigen Inc. of $72 million of common stock.
Humanigen Inc. is a clinical…
XPO Logistics $300 million senior notes reopening
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of an additional $300 million aggregate principal amount of 6.250%…
ADC Therapeutics $267 million IPO
Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which included the exercise in full by the underwriters of their option to…
Insulet $500 million stock offering
Davis Polk advised the underwriters in connection with the public offering of 2,369,668 shares of common stock of Insulet Corporation. The offering resulted in approximately $500…
Ayala Pharmaceuticals $55 million IPO
Davis Polk advised the underwriters in connection with the $55 million initial public offering of 3,666,667 shares of common stock of Ayala Pharmaceuticals, Inc. Ayala is traded on the…